Company Announcements

In March, 908 Devices closed $20 million in a growth equity funding round. New investors include Tao Capital Partners.

In 2016, Microsaic revenues increased 8.7% to £0.8 million ($1.1 million) as unit volumes increased 17%. However, the results were below expectations. Operating loss declined 13.3% to £3.3 million ($4.5 million). The company announced that it is now focused on the pharmaceutical market, including bioprocessing and diagnostics.

Microsaic announced in April a collaboration with software firm SCPA (Software für Chromatographie aunder Prozess-Analytik), integrating its 4000 MiD compact MS with SCPA’s PrepCon 5 preparative data and control software.

SCIEX announced in March that the Children’s Medical Research Institute opened ProCan, the Australian Cancer Research Foundation International Centre for the Proteome of Human Cancer. The Center, set up through an alliance with SCIEX, will help industrialize the process of analyzing tissue samples and identifying cancer biomarkers.

In March, Proteome Sciences announced that 2016 sales for Tandem Mass Tags (TMTs), which enable identification and quantitation of proteins in different samples using tandem MS, grew 57% to £1.4 million ($1.9 million). TMTs are sold by Thermo Fisher Scientific. Proteome Sciences is currently working on a new tag structure for 16-plex reagents, as well as 10-plex reagents for use with lower-resolution MS.

In April, Syft Technologies announced the listing of its shares on New Zealand’s Unlisted trading facility. For the year ending March 31, 2016, company revenues rose 15.7% to NZD 6.4 million ($4.4 million).

In April, Becton, Dickinson announced it will globally distribute MBT Biotargets, disposable plates, and the MBT Sepsityper sepsis management kit, as well as standard reagents and other products, for use with Bruker‘s MALDI Biotyper systems. The products are part of a complete portfolio for addressing antimicrobial resistance.

Product Introductions

In March, Waters launched Proteolabels software, an extension for Progenesis QI for proteomics, which supports studies involving stable isotope labels. It is available through an exclusive agreement with Omic Analytics.

Waters in March released the METLIN MS/MS Library for Progenesis QI for implementation of a METLIN library, a metabolomics database, directly within the Progenesis QI software.

In March, SCIEX introduced the Routine Biotransform Solution, comprised of the ExionLC AD system, X500 QTOF System and Metabolite Software 2.0 software. It also released the Advanced Biotransform Solution, based on SWATH Acquisition using the TripleTOF 6600 and MetabolitePilot Software 2.0. The company called the MetabolitePilot Software 2.0 the first commercial software to automate protein catabolite identification.

In April, Advion released the iASAP (inert Atmospheric Solids Analysis Probe) for easy sampling and fast analysis of air-sensitive compounds such as metal catalysts and organometallics.

Biognosys introduced in April SpectroDive 8.0, which supports library generation from DDA (Data Dependent Acquisition) and subsequent panel generation for data acquisition with MRM and PRM workflows.

Biognosys relaunched in April its blood proteomics portfolio. Its PlasmaDive and PlasmaDeepDive Assay Panels are now offered in 3 sizes: 20, 48 and 96 samples, and come with a license for SpectroDive software. Stable isotope labeled standard reference peptides are now available separately as PlasmaDive Reference Peptides and PlasmaDeepDive Reference Peptides kits.

In April, Bruker launched CE-IVD MBT STAR Carba IVD kits for its MALDI Biotyper for functional testing of high-risk Carbapenemase Antibiotic Resistance, calling it the first validated diagnostic assay MS-based resistance testing on the market. The company also released the CE-IVD MBT Mycobacterial IVD Library and Software module, which make mycobacteria identification available for clinical diagnostic purposes. In addition, the application portfolio of the MBT Subtyping Module was increased.